tirzepatide or wegovy F.D.A. Approves New Obesity Drug That Will Compete With Tirzepatide vs. semaglutide for weight

Wegovy (Novo Nordisk) Patient Support Program Eligibility: Must have private insurance that covers Wegovy, not receiving government drug benefits Savings: Up to $150 per monthly prescription for 12 months Maximum annual benefit: $1,800 How it works: Reduces out-of-pocket costs after insurance pays their portion Saxenda (Novo Nordisk) Patient Support Program Eligibility: Private insurance covering Saxenda, not on provincial drug plans Savings: Up to $120 per monthly prescription Maximum annual benefit: $1,440 How it works: Applied at pharmacy, reduces copay amount Expected Retatrutide Program (Not Yet Announced) Projected eligibility: Private insurance with Retatrutide coverage, not receiving provincial benefits Projected savings: $200-300 per monthly prescription based on medication cost Projected maximum benefit: $2,400-3,600 annually Expected launch: Same time as Health Canada approval The catch with Canadian savings programs: you need private insurance that already covers the medication

doi:10.1111/j.1463-1326.2009.01102.x 38

doi: 10.1007/s10068-025-01996-8

WangHWangYBoQLJiYLLiuLHuYFet alMaternal cadmium exposure reduces placental zinc transport and induces fetal growth restriction in mice

Eating fast might also lead to air getting stuck in the digestive system

The Rise of GLP-1 Medications and a New Skin Concern In recent years, prescriptions for semaglutide, tirzepatide, and liraglutide have skyrocketed